GlassScriptPhysician profile
Yelena Levitin
NPI 1235279860
$15,246.71
in general payments reported to CMS, 2019-2025
43 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $11K · 2021: $1,352 · 2022: $309 · 2023: $556 · 2024: $813 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,749.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $10,955.23 | 2020 | |
| Spineart USA INC | $1,026.04 | 2021 | |
| Abbvie INC. | $798.27 | 2019-2025 | |
| Kerecis Limited | $257.85 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Kci USA, INC. | $251.45 | 2019-2022 | |
| Integra Lifesciences Corporation | $217.38 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Smith+Nephew, INC. | $179.11 | 2019-2025 | Stravix Pl, Grafix Pl, Oasis |
| Vivus LLC | $136.49 | 2020-2025 | Qsymia |
| Medtronic, INC. | $134.54 | 2024 | Progrip |
| Pacira Pharmaceuticals Incorporated | $132.92 | 2019-2024 | Exparel, Iovera |
| Davol INC. | $106.37 | 2022-2025 | Phasix Mesh |
| Tela Bio, INC. | $86.76 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Echosens North America, INC. | $76.65 | 2023 | Fibroscan |
| Kowa Pharmaceuticals America, INC. | $76.65 | 2023 | Seglentis |
| W. L. Gore & Associates, INC. | $70.67 | 2023-2024 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yelena Levitin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.